Signaling Pathways - Vascular Disrupting Agents (VDA) - Sphingosine kinases (SphKs) - Na /K ATPases - PD-1/PD-L1 interaction
清除全部
- B6023 PD-1/PD-L1 inhibitor 2Target: PD-1/PD-L1 interactionSummary: PD-1/PD-L1相互作用的抑制剂
- B7705 Lithium carbonate中文名: 碳酸锂Target: Na /K ATPasesSummary: Na+/K+ ATPase抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2298 Plinabulin (NPI-2358)中文名: 普那布林Target: Vascular Disrupting Agents (VDA)Summary: 血管破坏剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A3507 Istaroxime1 CitationTarget: Na /K ATPasesSummary: Na+/K+ ATPase的抑制剂